(From The Prague Post)
Byline: Petra Pasternak
How Zentiva pulled off the country's first IPO in more than a decade
Petr Polievka was stressed. His managers did not take well at first to their hefty new load of administrative tasks and extra meetings.
But two months after taking the country's largest pharmaceutical company public, Polievka, the director of corporate governance for Zentiva, looks back at his company's initial public offering (IPO) as a valuable learning experience.
"It took us six months to prepare the company," said Polievka, whose company operates across Central and Eastern Europe and controls roughly 40 percent of the pharmaceutical market in the Czech Republic. "We had to deal with dozens of questions from countless experts during due diligence while still doing our daily tasks to ensure the company's smooth running."
Today Zentiva …